Mirtazapine
Major depressive disorder (MDD)
Boxed warning
- WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors [see Warnings and Precautions (5.1) ] . Mirtazapine tablets are not approved for use in pediatric patients [see Use in Specific Populations (8.4) ] . WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See full prescribing ... (see full label)
Indications
- Major depressive disorder (MDD)
Adult dosing
- mdd initial: dose: 15; unit: mg; route: PO; interval: once daily, increase up to 45 mg per day if inadequate response; fixed: true; labelExcerpt: The recommended starting dose of mirtazapine tablets is 15 mg once daily, administered orally, preferably in the evening prior to sleep. If patients do not have an adequate response to the initial 15 mg dose, increase the dose up to a maximum of 45 mg per day.
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- moderate: Dosage decrease may be needed; severe: Dosage decrease may be needed; failure: Dosage decrease may be needed; note: Clearance reduced ~30% in GFR 11–39 mL/min and ~50% in GFR <10 mL/min. Label: "When compared to subjects with normal renal function, total body clearance of mirtazapine was reduced approximately 30% in renal impaired patients with GFR = 11–39 mL/min/1.73 m 2 and approximately 50% in renal impaired patients with GFR = < 10 mL/min/1.73 m 2"
Hepatic adjustment
- Dosage decrease may be needed.
Contraindications
- MAOI use within 14 days
- Known hypersensitivity to mirtazapine
Clinical pearls
- Administer once daily, preferably in the evening prior to sleep.
- Monitor for clinical worsening and emergence of suicidal thoughts.
- May cause increased appetite and weight gain.
- Discontinue if agranulocytosis or severe neutropenia is suspected (e.g., fever, sore throat).
Source and review
- DailyMed label (mirtazapine), Set ID 412abf0e-1f96-4d4d-bb56-a23d4699b14c, effective 2026-09-04. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties